SLC1A5 and cancer: Previous groups have demonstrated increased expression of amino acid transporters, including ASCT2 and LAT1, in metastatic brain cancer as well as in cancers of the kidney, colon, endometrium, stomach, liver, lung, ovary, pancreas, and prostate [2,9].